This week, the US FDA released guidance documents on COVID-19 monoclonal antibodies and the use of digital health technologies in remote trials; Philips’ Biotelemetry pays $14.7m to settle False Claims Act allegations; recalls of bronchoscopes, tracheostomy trays and software; and more.
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022. Here are some highlights from the in vitro diagnostics companies that presented on the first two days of the meeting.
Philips is already the leader in hospital patient monitoring and adding BioTelemetry will make it also the top provider of ambulatory cardiac diagnostics and monitoring systems.
Artificial intelligence is all the range for medical device manufacturers, but how do physicians really feel about it?
CINCINNATI (WXIX) - Cincinnati-based The Kroger Co. is under federal investigation for alleged False Claims Act violations in its opioid dispensing practices, according to newly filed court record...